Cargando…
Implementing prescribing safety indicators in prisons: A mixed methods study
AIMS: To examine the prevalence of potentially hazardous prescribing in the prison setting using prescribing safety indicators (PSIs) and explore their implementation and use in practice. METHODS: PSIs were identified and reviewed by the project team following a literature review and a nominal group...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297974/ https://www.ncbi.nlm.nih.gov/pubmed/34625991 http://dx.doi.org/10.1111/bcp.15107 |
_version_ | 1784750594904293376 |
---|---|
author | Abuzour, Aseel S. Magola‐Makina, Esnath Dunlop, James O'Brien, Amber Khawagi, Wael Y. Ashcroft, Darren M. Brown, Petra Keers, Richard N. |
author_facet | Abuzour, Aseel S. Magola‐Makina, Esnath Dunlop, James O'Brien, Amber Khawagi, Wael Y. Ashcroft, Darren M. Brown, Petra Keers, Richard N. |
author_sort | Abuzour, Aseel S. |
collection | PubMed |
description | AIMS: To examine the prevalence of potentially hazardous prescribing in the prison setting using prescribing safety indicators (PSIs) and explore their implementation and use in practice. METHODS: PSIs were identified and reviewed by the project team following a literature review and a nominal group discussion. Pharmacists at 2 prison sites deployed the PSIs using search protocols within their electronic health record. Prevalence rates and 95% confidence intervals (CIs) were generated for each indicator. Semi‐structured interviews with 20 prison healthcare staff across England and Wales were conducted to explore the feasibility of deploying and using PSIs in prison settings. RESULTS: Thirteen PSIs were successfully deployed mostly comprising drug–drug interactions (n = 9). Five yielded elevated prevalence rates: use of anticholinergics if aged ≥65 years (Site B: 25.8% [95%CI: 10.4–41.2%]), lack of antipsychotic monitoring for >12 months (Site A: 39.1% [95%CI: 27.1–52.1%]; Site B: 28.6% [95%CI: 17.9–41.4%]), prolonged use of hypnotics (Site B: 46.3% [95%CI: 35.6–57.1%]), antiplatelets prescribed with nonsteroidal anti‐inflammatory drugs without gastrointestinal protection (Site A: 12.5% [95%CI: 0.0–35.4%]; Site B: 16.7% [95%CI: 0.4–64.1%]), and selective serotonin/norepinephrine reuptake inhibitors prescribed with nonsteroidal anti‐inflammatory drugs/antiplatelets without gastrointestinal protection (Site A: 39.6% [95%CI: 31.2–48.4%]; Site B: 33.3% [95%CI: 20.8–47.9%]). Prison healthcare staff supported the use of PSIs and identified key considerations to guide its successful implementation, including staff engagement and PSI 'champions'. To respond to PSI searches, stakeholders suggested contextualised patient support through intraprofessional collaboration. CONCLUSION: We successfully implemented a suite of PSIs into 2 prisons, identifying those with higher prevalence values as intervention targets. When appropriately resourced and integrated into staff workflow, PSI searches may support prescribing safety in prisons. |
format | Online Article Text |
id | pubmed-9297974 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92979742022-07-21 Implementing prescribing safety indicators in prisons: A mixed methods study Abuzour, Aseel S. Magola‐Makina, Esnath Dunlop, James O'Brien, Amber Khawagi, Wael Y. Ashcroft, Darren M. Brown, Petra Keers, Richard N. Br J Clin Pharmacol Original Articles AIMS: To examine the prevalence of potentially hazardous prescribing in the prison setting using prescribing safety indicators (PSIs) and explore their implementation and use in practice. METHODS: PSIs were identified and reviewed by the project team following a literature review and a nominal group discussion. Pharmacists at 2 prison sites deployed the PSIs using search protocols within their electronic health record. Prevalence rates and 95% confidence intervals (CIs) were generated for each indicator. Semi‐structured interviews with 20 prison healthcare staff across England and Wales were conducted to explore the feasibility of deploying and using PSIs in prison settings. RESULTS: Thirteen PSIs were successfully deployed mostly comprising drug–drug interactions (n = 9). Five yielded elevated prevalence rates: use of anticholinergics if aged ≥65 years (Site B: 25.8% [95%CI: 10.4–41.2%]), lack of antipsychotic monitoring for >12 months (Site A: 39.1% [95%CI: 27.1–52.1%]; Site B: 28.6% [95%CI: 17.9–41.4%]), prolonged use of hypnotics (Site B: 46.3% [95%CI: 35.6–57.1%]), antiplatelets prescribed with nonsteroidal anti‐inflammatory drugs without gastrointestinal protection (Site A: 12.5% [95%CI: 0.0–35.4%]; Site B: 16.7% [95%CI: 0.4–64.1%]), and selective serotonin/norepinephrine reuptake inhibitors prescribed with nonsteroidal anti‐inflammatory drugs/antiplatelets without gastrointestinal protection (Site A: 39.6% [95%CI: 31.2–48.4%]; Site B: 33.3% [95%CI: 20.8–47.9%]). Prison healthcare staff supported the use of PSIs and identified key considerations to guide its successful implementation, including staff engagement and PSI 'champions'. To respond to PSI searches, stakeholders suggested contextualised patient support through intraprofessional collaboration. CONCLUSION: We successfully implemented a suite of PSIs into 2 prisons, identifying those with higher prevalence values as intervention targets. When appropriately resourced and integrated into staff workflow, PSI searches may support prescribing safety in prisons. John Wiley and Sons Inc. 2021-10-29 2022-04 /pmc/articles/PMC9297974/ /pubmed/34625991 http://dx.doi.org/10.1111/bcp.15107 Text en © 2021 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Abuzour, Aseel S. Magola‐Makina, Esnath Dunlop, James O'Brien, Amber Khawagi, Wael Y. Ashcroft, Darren M. Brown, Petra Keers, Richard N. Implementing prescribing safety indicators in prisons: A mixed methods study |
title | Implementing prescribing safety indicators in prisons: A mixed methods study |
title_full | Implementing prescribing safety indicators in prisons: A mixed methods study |
title_fullStr | Implementing prescribing safety indicators in prisons: A mixed methods study |
title_full_unstemmed | Implementing prescribing safety indicators in prisons: A mixed methods study |
title_short | Implementing prescribing safety indicators in prisons: A mixed methods study |
title_sort | implementing prescribing safety indicators in prisons: a mixed methods study |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297974/ https://www.ncbi.nlm.nih.gov/pubmed/34625991 http://dx.doi.org/10.1111/bcp.15107 |
work_keys_str_mv | AT abuzouraseels implementingprescribingsafetyindicatorsinprisonsamixedmethodsstudy AT magolamakinaesnath implementingprescribingsafetyindicatorsinprisonsamixedmethodsstudy AT dunlopjames implementingprescribingsafetyindicatorsinprisonsamixedmethodsstudy AT obrienamber implementingprescribingsafetyindicatorsinprisonsamixedmethodsstudy AT khawagiwaely implementingprescribingsafetyindicatorsinprisonsamixedmethodsstudy AT ashcroftdarrenm implementingprescribingsafetyindicatorsinprisonsamixedmethodsstudy AT brownpetra implementingprescribingsafetyindicatorsinprisonsamixedmethodsstudy AT keersrichardn implementingprescribingsafetyindicatorsinprisonsamixedmethodsstudy |